Assignee
PHARMA MAR SA
ES·61 granted patents·51 pending applications·748 citations·filing 1994–2025
Top patents by PatentIndex Score
112 records- 0194US11339180B2Antitumoral compoundsPHARMA MAR SA·Filed 2021·Granted May 24, 2022·3 cites·22 claims
- 0294US7420051B2Synthetic process for the manufacture of an ecteinaschidin compoundPHARMA MAR SA·Filed 2005·Granted Sep 2, 2008·29 cites·16 claims
- 0393US7410969B2Antitumoral analogs of ET-743PHARMA MAR SA·Filed 2005·Granted Aug 12, 2008·32 cites·66 claims
- 0492US7524956B2Hemisynthetic method and new compoundsPHARMA MAR SA·Filed 2007·Granted Apr 28, 2009·32 cites·6 claims
- 0590US12324806B2Method of treating SCLC and managing hepatotoxicityPHARMA MAR SA·Filed 2023·Granted Jun 10, 2025·2 cites·30 claims
- 0690US7795260B2Synthesis of naturally occurring ecteinascidins and related compoundsPHARMA MAR SA·Filed 2008·Granted Sep 14, 2010·9 cites·22 claims
- 0789US7348311B2Derivatives of dehydrodidemnin BPHARMA MAR SA·Filed 2005·Granted Mar 25, 2008·11 cites·14 claims
- 0889USRE39887EDehydrodidemnin BPHARMA MAR SA·Filed 2005·Granted Oct 16, 2007·12 cites·5 claims
- 0989US7241892B1Hemisynthetic method and new compoundsPHARMA MAR SA·Filed 2000·Granted Jul 10, 2007·40 cites·99 claims
- 1089US6710029B1Dehydrodidemnin BPHARMA MAR SA·Filed 2000·Granted Mar 23, 2004·28 cites·9 claims
- 1188US6867334B2Metabolites of ecteinascidin 743 formed by human cytochrome CYP3A4PHARMA MAR SA·Filed 2001·Granted Mar 15, 2005·37 cites·2 claims
- 1287US10538535B2Antitumoral compoundsPHARMA MAR SA·Filed 2018·Granted Jan 21, 2020·7 cites·51 claims
- 1387US7919493B2Anititumoral ecteinascidin derivativesPHARMA MAR SA·Filed 2007·Granted Apr 5, 2011·9 cites·47 claims
- 1487US7678765B2Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using themPHARMA MAR SA·Filed 2007·Granted Mar 16, 2010·9 cites·14 claims
- 1587US7247629B2Antitumoral analogs of et-743PHARMA MAR SA·Filed 2001·Granted Jul 24, 2007·28 cites·92 claims
- 1686US2026014148A1Method of treating sclc and managing neutropeniaPHARMA MAR SA·Filed 2025·Application pending·0 cites
- 1785US11332480B2Antitumoral compoundsPHARMA MAR SA·Filed 2018·Granted May 17, 2022·2 cites·20 claims
- 1885US2026076964A1Method of treating sclc and managing hepatotoxicityPHARMA MAR SA·Filed 2025·Application pending·0 cites
- 1985US2026076965A1Method of treating sclc and managing thrombocytopeniaPHARMA MAR SA·Filed 2025·Application pending·0 cites
- 2084US8012975B2Antitumoral analogs of ET-743PHARMA MAR SA·Filed 2006·Granted Sep 6, 2011·7 cites·74 claims
- 2184US7772241B2Variolin derivatives and their use as antitumor agentsPHARMA MAR SA·Filed 2009·Granted Aug 10, 2010·5 cites·25 claims
- 2283US12384800B2Antitumoral compoundsPHARMA MAR SA·Filed 2023·Granted Aug 12, 2025·0 cites·23 claims
- 2383US7947671B2Synthesis of naturally occuring ecteinascidins and related compoundsPHARMA MAR SA·Filed 2010·Granted May 24, 2011·7 cites·23 claims
- 2483US2023399344A1A lyophilized pharmaceutical compositionPHARMA MAR SA·Filed 2023·Application pending·0 cites
- 2583US2023416276A1Lyophilized pharmaceutical composition and uses of a crystallized form of lurbinectedinPHARMA MAR SA·Filed 2023·Application pending·0 cites
- 2683US2023399345A1Crystallized form of lurbinectedin and method of making the samePHARMA MAR SA·Filed 2023·Application pending·0 cites
- 2782US12440490B2Method of treating SCLC and managing thrombocytopeniaPHARMA MAR SA·Filed 2023·Granted Oct 14, 2025·0 cites·30 claims
- 2882US12433890B2Method of treating SCLC and managing neutropeniaPHARMA MAR SA·Filed 2023·Granted Oct 7, 2025·0 cites·30 claims
- 2982US7482429B2Kahalalide F and related compoundsPHARMA MAR SA·Filed 2001·Granted Jan 27, 2009·33 cites·49 claims
- 3082US7348310B2Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using themPHARMA MAR SA·Filed 2001·Granted Mar 25, 2008·13 cites·41 claims
- 3182US7115743B2Metabolites of ecteinascidin 743PHARMA MAR SA·Filed 2004·Granted Oct 3, 2006·17 cites·2 claims
- 3281US7767659B2Synthesis of naturally occurring ecteinascidins and related compoundsPHARMA MAR SA·Filed 2003·Granted Aug 3, 2010·10 cites·16 claims
- 3381US6011010ACytotoxic and antiviral compoundPHARMA MAR SA·Filed 1997·Granted Jan 4, 2000·32 cites·4 claims
- 3480US7763615B2Ecteinascidin analogs for use as antitumour agentsPHARMA MAR SA·Filed 2002·Granted Jul 27, 2010·16 cites·32 claims
- 3579US11713325B2Antitumoral compoundsPHARMA MAR SA·Filed 2022·Granted Aug 1, 2023·0 cites·22 claims
- 3678US9827257B2Antitumoral compoundsPHARMA MAR SA·Filed 2015·Granted Nov 28, 2017·5 cites·14 claims
- 3778US5834586ADehydrodidemnin BPHARMA MAR SA·Filed 1994·Granted Nov 10, 1998·38 cites·5 claims
- 3877US7473681B2Kahalalide FPHARMA MAR SA·Filed 2001·Granted Jan 6, 2009·16 cites·7 claims
- 3975US7495000B2Variolin derivatives and their use as antitumor agentsPHARMA MAR SA·Filed 2002·Granted Feb 24, 2009·7 cites·36 claims
- 4075US5786492AHalichondrinsPHARMA MAR SA·Filed 1997·Granted Jul 28, 1998·25 cites·4 claims
- 4173US11224663B2Antibody drug conjugatesPHARMA MAR SA·Filed 2014·Granted Jan 18, 2022·2 cites·30 claims
- 4273US7759345B2Antitumoral derivatives of ET-743PHARMA MAR SA·Filed 2002·Granted Jul 20, 2010·6 cites·20 claims
- 4373US7138547B2Antitumoral compoundsPHARMA MAR SA·Filed 2001·Granted Nov 21, 2006·9 cites·13 claims
- 4472US7320981B2Variolin derivatives as anti-cancer agentsPHARMA MAR SA·Filed 2001·Granted Jan 22, 2008·8 cites·45 claims
- 4572US7135494B2Antitumoral carbazolesPHARMA MAR SA·Filed 2001·Granted Nov 14, 2006·11 cites·28 claims
- 4672US6864283B2Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activityPHARMA MAR SA·Filed 2001·Granted Mar 8, 2005·5 cites·10 claims
- 4772US6153731ADehydrodidemnin BPHARMA MAR SA·Filed 1998·Granted Nov 28, 2000·30 cites·2 claims
- 4871US2023014782A1New solid state form of lurbinectedinPHARMA MAR SA·Filed 2020·Application pending·0 cites
- 4970US7507766B2Treatment of cancersPHARMA MAR SA·Filed 2001·Granted Mar 24, 2009·12 cites·9 claims
- 5069US7329666B2Derivatives of variolin BPHARMA MAR SA·Filed 2001·Granted Feb 12, 2008·11 cites·23 claims
Showing the top 50 of 112 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →